Your browser doesn't support javascript.
loading
Cost-Effectiveness Comparison between Ticagrelor and Clopidogrel in Acute Coronary Syndrome in Iran.
Hashemi-Meshkini, Amir; Tajik, Amirmohammad; Ayati, Nayyereh; Nikfar, Shekoufeh; Koochak, Reza; Yaghoubifard, Saeed; Abbasi, Azam; Varmaghani, Mehdi.
Afiliação
  • Hashemi-Meshkini A; Department of Pharmacoeconomics and Pharmaceutical Administration, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
  • Tajik A; School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Ayati N; Department of Pharmacoeconomics and Pharmaceutical Administration, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
  • Nikfar S; Department of Pharmacoeconomics and Pharmaceutical Administration, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
  • Koochak R; Evidence-Based Evaluation of Cost-Effectiveness and Clinical Outcomes Group, Pharmaceutical Sciences Research Center (PSRC), and the Pharmaceutical Management and Economics Research Center (PMERC), the Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran.
  • Yaghoubifard S; Promethean BioPharma Limited, Sydney, Australia.
  • Abbasi A; Department of Pharmacoeconomics and Pharmaceutical Administration, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
  • Varmaghani M; Department of Management Sciences and Health Economics, School of Health, Mashhad University of Medical Sciences, Mashhad, Iran.
J Tehran Heart Cent ; 18(2): 94-101, 2023 Apr.
Article em En | MEDLINE | ID: mdl-37637281
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation / Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation / Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article